Home >> Marketplace Archives >> Disease state sera, 12/17

Disease state sera, 12/17

Print Friendly, PDF & Email


December 2017—Binding Site’s Immunologicals Group offers a comprehensive line of disease state sera in its portfolio of products available to in vitro diagnostic manufacturers and clinical research facilities. The line of products follows all current regulatory and quality standards guidelines and provides materials from a variety of disease state conditions, including ANAs, ANCAs, aPLs, ENAs, infectious and contagious diseases, inflammation markers, and autoantibodies focused on a variety of human organs and tissues. Materials are available in bulk formats and in volumes of up to 3 L per unit for use in the manufacturing of calibration and/or quality control materials. Sample material is available on request. The company can offer
comprehensive data on analyte positive as well as negative data, along with a comprehensive certificate of analysis.

Binding Site, 800-633-4484


Check Also

IgG subclass antibodies

June 2018—Binding Site’s Immunologicals Group announced the availability of affinity-purified, unconjugated, anti-human antibodies to the IgG subclasses, including IgG1, IgG2, IgG3, and IgG4, for IVD research use in solid phase enzyme immunoassay based test methods, especially ELISAs, and other potential testing applications.